INTRODUCTION
Progress in influenza virus research has been aided by a viral reverse genetics system and the availability of clinical isolates of varying pathogenicity that have been adapted to the mouse model to mimic human disease. The widely accepted murine model permits detailed study of the innate and adaptive immune responses to influenza virus due to the availability of reagents such as antibodies and gene knockout animals. However, the usefulness of the murine system has been severely limited by the lack of a corresponding mouse lung epithelial cell culture model that can be used to analyse viral replication dynamics and host cell responses during spreading infection. It has been shown that influenza virus productively infects type I and type II epithelial cells in both humans and mice, and that these cells serve as the replicative niche for the virus (Chan et al., 2010; Sanders et al., 2011; Shieh et al., 2010) . Furthermore, in humans, pigs and ferrets, type I epithelial cells are the predominant cell type infected in the alveolus by the commonly circulating human influenza virus serotypes, H1N1 and H3N2 (van Riel et al., 2007) . Type I epithelial cells comprise 90 % of cells in the alveolar surface but only~4 % of cells in the whole lung, while type II epithelial cells cover 10 % of the alveolar surface but are~20 % of total lung cells (Crapo et al., 1982; Marsh et al., 2009) . Murine tracheal epithelial cells (mTECs) provide a good in vitro model for influenza virus infection of tracheal cells, but wide use of these cells is limited by their low yield, technical challenge and inability to be genetically manipulated. Influenza virus also infects murine haematopoietic cells such as lung macrophages and dendritic cells, either through direct uptake of virus or phagocytosis of infected epithelial cells, but these cell types are not considered to be a major source of infectious progeny virions (Hashimoto et al., 2007; Manicassamy et al., 2010) . Since epithelial cells are the essential niche for the initial round of influenza virus replication within the lung, the ability of a viral strain to replicate within these cells is an important determinant of pathogenicity. Replication rate is influenced by properties of the virus as well as by the ability of a given host cell to activate cell-intrinsic mechanisms of restricting viral growth and to release soluble mediators, such as type I and type III IFN, that elicit an antiviral state in uninfected bystander cells. This highlights the importance of studying spreading infection in epithelial cells.
In vitro characterization of the influenza virus life cycle and cellular responses has relied on infection of epithelial or fibroblast cells from a variety of organs and species, but data derived from these host cell models cannot necessarily be extrapolated to understand how lung type I epithelial cells respond to spreading infection within the murine influenza virus model. Primary lung type I epithelial cells can be isolated by flow cytometry and cultured, but the low yield prohibits many types of experiments. An available lung type I epithelial cell line (TC-1) can be infected by influenza virus, but with low efficiency, and it is non-permissive for a complete viral life cycle. To understand how type I epithelial cells respond to influenza virus infection, we have immortalized primary mouse lung type I epithelial cells using a retrovirus expressing SV40 large T antigen. We have characterized influenza virus replication dynamics and host responses and identified the role of type I IFN produced by type I epithelial cells in orchestrating the innate host response to limit influenza virus replication.
RESULTS

Generation of the LET1 lung type I epithelial cell line
Lung type I epithelial cells provide a replicative niche for influenza virus within the human lower respiratory tract. In order to validate that T1-a-positive type I epithelial cells were infected by influenza virus in the murine influenza model, we used flow cytometry to check for viral protein expression at an early time point of infection (Fig. 1a) . Since type I epithelial cells are naturally infected by influenza virus in vivo and cover the majority of the alveolar surface (Marsh et al., 2009) , we were interested in characterizing their response to influenza virus infection as well as the dynamics of viral replication. An existing lung type I epithelial cell line (TC-1) can be infected by influenza virus in vitro and permits replication of viral RNA (Fig. 1b) and modest production of de novo influenza virus nucleoprotein (NP) (Fig. 1c) . However, even with increased viral inocula we were unable to infect more than 10 % of our monolayer, and this percentage did not increase over 48 h (Fig. 1c and data not shown). Furthermore, infected TC-1 cultures did not release virions that could be detected by plaque assay, and treatment of TC-1 cells for 24 h with media collected from infected TC-1 cultures did not result in matrix (M) gene expression by quantitative real-time reverse transcription PCR (qRT-PCR) or NP staining by flow cytometry (data not shown). Based on these data, TC-1 cells do not support the full influenza virus life cycle and permit spreading infection, making them a poor model for influenza virus infection of the lung.
To understand viral replication dynamics and the corresponding antiviral responses of influenza virus-infected lung type I epithelial cells, we began by isolating mouse lung type I epithelial cells by FACS, defined as those cells expressing T1a
+ and negative for CD45 (haematopoietic cells), Sca-1 (lung stem cells), Ter-119 (erythroid cells) and autofluorescence (type II epithelial cells) (Fig. 2a) . Since the yield of these primary type I lung epithelial cells (¡10 5 per mouse) was insufficient for a wide range of experiments, we attempted to immortalize them using a retrovirus expressing SV40 large T antigen. While we were unable to derive a line of cells by transducing freshly sorted T1a + cells, we successfully immortalized cells following culture of total lung epithelial cells for 5 days. The majority of these cells expressed high levels of the type I epithelial cell lineage-specific marker T1a, and further FACS sorting removed rare T1a 2 cells to establish a pure lung type I epithelial cell population, denoted LET1 (lung epithelial type I) (Fig. 2b) . Their generation time was ,24 h when cultured in standard media Dulbecco's modified Eagle's medium (DMEM) containing 10 % FBS. Comparable viral replication was observed between LET1 cells and FACSisolated primary T1a
+ lung cells, with a tenfold increase in influenza viral transcripts over 24 h (Fig. 2c, d ). In comparison with other cell lines used to study influenza virus, the increase in viral transcripts observed in LET1 cells was much greater than in the TC-1 cell line, comparable with mouse fibroblasts (3T3) and human fibroblasts (MRC-5) and less than Madin-Darby canine kidney (MDCK) cells (a highly permissive cell line used for influenza virus production) and primary polarized mouse tracheal epithelial cells (mTECs) (Fig. 2c) .
Characterization of spreading influenza virus infection in LET1 cells
We proceeded to characterize the replication dynamics of PR8 influenza virus within LET1 cells using qRT-PCR by measuring total levels of viral M gene (Fig. 3a) , as well as each of the three RNA species (vRNA, mRNA and cRNA), separately (Fig. 3b) . Influenza virus is a single-stranded negative-sense RNA virus, and we measured an increasing abundance of negative-sense vRNA above the quantity contributed by the infecting virions at 2 h (Fig. 3b) . We also observed robust transcription of positive-sense mRNA and cRNA within 4 h (Fig. 3b) , which are RNA species not contained in the virus but are transcribed within host cells. LET1 cells support viral protein production, as measured by flow cytometry of influenza virus PR8 infected and uninfected cells stained with NP-specific antibodies (Fig.  3c ). This represents de novo protein synthesis, as NP staining on cells infected for 2 h was indistinguishable from uninfected cells (data not shown). Finally, to determine whether LET1 cells released infectious progeny virions, we collected supernatants from influenza virus-infected LET1 cells 24 h post-infection and transferred these supernatants to naïve LET1 cells or MDCK cells. In both cases, virus released by LET1 cells was able to infect naïve cells to produce viral mRNA and vRNA ( Fig. 3d and data not shown), as well as NP protein (Fig. 3e) . We reproducibly observed decreased NP expression levels in cells infected with virus contained in supernatants from infected LET1 cells compared to cells infected with purified PR8 virus (Fig. 3e) . These supernatant transfer experiments, together with the measured transcription of positive-sense viral RNA and translation of viral protein, indicate that LET1 cells are productively infected by influenza virus and provide an appropriate model for studying the infectious life cycle.
In order to more broadly determine the capacity of LET1 cells to produce infectious virions, we infected confluent monolayers with a panel of human, swine and mouse-adapted (Fig. 4a) . To test whether LET1 cells are a good model for mouse lung infection phenotypes, we tested their ability to support the replication of four influenza virus strains: the mouse-adapted H1N1 PR8 and H3N2 X31 strains and two 2009 swine-origin panH1N1 strains, a human clinical isolate and a closely related mouseadapted strain. As shown in Fig. 4(b) , LET1 cells were the most permissive for replication of the PR8 strain, which has been well adapted to the mouse model. LET1 cells were more permissive for replication of the mouse-adapted H1N1 CA/04 virus than with the human isolate, which does not replicate well within mouse lungs (Fig. 4b, c) . The infectivity of most cell lines used for influenza virus research can be increased by the addition of exogenous tosyl phenylalanyl chloromethyl ketone (TPCK)-treated trypsin. Trypsin was not required for multi-cycle replication, and we did not observe a significant increase in the quantity of infectious virus released by LET1 cells cultured in the presence of 0.02 mg ml 21 trypsin (Fig.  4b) , while higher concentrations (0.2-2 mg ml
21
) caused the cells to detach. Culture in the presence of trypsin did not increase the infectivity of released virus when transferred to new cells (Fig. 4c ). This suggests that LET1 cells produce a protease that cleaves influenza virus haemagglutinin, permitting a spreading infection (Ilyushina et al., 2010; Sakabe et al., 2011) . PR8 is more pathogenic in mice than X31, but we observed greater replication kinetics for X31 in this model of type I lung epithelial cells (Fig. 4d) .
In order to further characterize LET1 cells, we checked the viral replication of three other RNA viruses in these cells; robust replication of Sendai virus, encephalomyocarditis virus (EMCV) and vesicular stomatitis virus (VSV) was observed ( Fig. 4e and data not shown). We observed replication of two strains of Sendai virus (Enders and Z), a mouse respiratory parainfluenza virus, and the released virus was capable of lytic infection as quantified by TCID 50 assay (Fig. 4e) . LLC-MK2 cells (MK2), a commonly used cell line for studying Sendai virus, released higher titres of virus than LET1 cells, analogous to the increased permissiveness of MDCK cells to release more influenza virus than LET1 cells.
LET1 cells grown on Transwell inserts could be grown at an air-liquid interface. We did not observe increased electrical resistance or localization of the tight junction protein ZO-1 at the cell periphery (data not shown), suggesting that tight junction formation was not established. However, differentiated cultures restricted the flow of liquid from the basolateral to the apical chamber, and therefore may model the polarized release of virus and cytokines by differentiated lung type I epithelial cells. LET1 cells cultured on ). Freshly isolated primary T1-a+ cells and immortalized LET1 cells were infected in vitro with influenza virus PR8 (m.o.i.55) and the inoculum was removed after 1 h. Viral RNA was measured at the indicated times by qRT-PCR using random-primed cDNA and primers specific for viral M gene and EF-1. Means±SEM are shown for two to three independent experiments. Similar viral growth was observed in primary cells following in vitro culture for 5 days.
Transwell inserts were permissive for viral replication ( Fig.  5a ) and we measured selective release of virions into the apical media (Fig. 5b) .
Characterization of lung type I epithelial responses to influenza virus infection
It is not unusual for transformed cells to lose some normal responses to viral infection. Therefore, we examined the transcriptional responses of infected LET1 cells to ensure an intact antiviral response to influenza virus. To determine whether LET1 cells recapitulate the antiviral responses of non-transformed cells, we compared mRNA expression profiles of primary type I lung epithelial cells and LET1 cells using qRT-PCR. As shown in Fig. 6 , there was a remarkably similar expression fingerprint in both cell types at baseline and the upregulated expression of a large range of genes relevant to antiviral responses following infection.
The predominance of type I IFN-regulated genes in the transcriptional programme activated in influenza-infected LET1 cells suggests that these cells are capable of producing type I IFNs. Indeed, we measured release of IFN-b by cells infected with mouse-adapted PR8 or human Udorn virus (Fig. 7a) . We also measured release of IL-6 and multiple chemokines (Fig. 7b ). Since lung cytokine responses are measured in bronchoalveolar lavage fluid collected from influenza-infected mice, we were interested in understanding whether both tracheal and alveolar epithelial cells could apically secrete these cytokines. mTEC tracheal epithelial cells are currently the only available primary mouse line that can be polarized to study apically restricted cytokine secretion. We compared the secretion profile of cytokines and chemokines from LET1 lung epithelial cells and primary polarized using a 32-plex Luminex panel (Fig.  7b, c ). There were similarities in the secretion of cytokines such as IL-6 and KC, in contrast to greater secretion of MCP-1 by lung epithelial cells when compared with tracheal cells. These cells provide a model to test hypotheses on the possible cellular sources of cytokines quantified in the bronchoalveolar lavage fluid collected from infected mice.
The ability to perturb host gene expression within relevant cell lines would permit functional dissection of in vivo phenotypes. To evaluate whether LET1 cells are genetically tractable, we performed gain-of-function and loss-offunction studies using retroviral or lentiviral expression of mRNA, microRNA (miRNA) or small hairpin RNA (shRNA). TNF receptor-associated factor (TRAF6) controls important antiviral programmes by regulating both NF-kB and IFN regulatory factor (IRF)-dependent transcriptional networks, but influenza virus replication in TRAF6-deficient cells has not been explored. Fig. 8 (a) demonstrates that virally transduced cells can be drug selected to stably overexpress TRAF6 (100 times WT levels). Fig. 8 (b, d) illustrates that we have been able to perform the converse experiment to decrease TRAF6 expression in LET1 cells by expressing TRAF6-specific shRNAs or ectopic miR-146a (a negative regulator of TRAF6), since TRAF6-deficient mice are unavailable. Viral replication was increased when TRAF6 levels were impaired by either approach (Fig. 8c, e) . LET1 cells therefore offer a tractable model for gain-of-function and loss-of-function studies in a murine lung epithelial cell line. The inoculum was removed after 1 h by washing, and TCID 50 in cell supernatants were calculated after 6, 12, 18 and 24 h of infection. Means ±SEM are shown for three replicates. (c) Cells were infected as described in (b). Virus released into supernatants after 6 h were transferred to new LET1 cells, removed after 1 h by washing, and TCID 50 in cell supernatants from a second round of infection were calculated after 6 and 24 h of infection. Means ±SEM are from three replicates and are representative of three independent experiments. (d) LET1 cells were infected with equivalent inocula of PR8 or X31 as described in Fig. 3(a) and viral RNA quantified at the indicated time points; means±SD are shown for two replicates and data are representative of three independent experiments, *P,0.01. (e) LET1 or MK2 cells were infected with two strains of Sendai virus (Enders or Z) in the presence or absence of exogenous trypsin. Virus released at the indicated time points over 48 h was quantified by TCID 50 on MK2 cells.
epithelial-derived type I IFN compared with professional IFN-producing cells, such as plasmacytoid dendritic cells, is not fully understood. LET1 cells were derived from IFN alpha and beta receptor 1 (IFNAR1) knockout mice to examine IFN-dependent antiviral responses in the absence of any other IFN-producing cells and to study the expression of host genes with upregulated expression in response to type I IFN. Epithelial cells unable to respond to type I IFN are impaired in their ability to control influenza virus replication, as measured by qRT-PCR for viral M gene (Fig. 8f ). This correlated with a muted baseline expression level of many type I IFN-regulated genes within IFNAR null cells (Fig. 8g ). In addition, there was also decreased expression of a module of genes with putative or demonstrated antiviral activities (Ifi203, Ifi44, Ifit3, Irf7, Mpa2l, Mx1, Oas3, Rsad2 and Trim30) following 24 h infection of IFNAR null LET1 cells compared with their WT counterparts (Fig. 8h) . Reduced expression of antiviral effectors provides a possible mechanism underlying the impaired ability of IFNAR null cells to control influenza virus replication. The impaired antiviral phenotype of IFNAR null LET1 cells correlated with increased permissiveness for viral protein production, as measured by FACS analysis of NP expression (Fig. 8i, j) . There was a notable increase in viral protein even within the first round of viral replication in the absence of type I IFN signalling, as measured by increased NP staining of IFNAR null cells after 6 h of infection (Fig. 8i) . To evaluate whether the amount of IFN produced by LET1 cells (Fig. 7a) is sufficient to increase the antiviral state of neighbouring cells, and thereby decrease their infectability, we tested the capacity of media conditioned by infected LET1 cells to suppress infection of a new culture. Supernatant was collected from LET1 cells infected for 24 h; released virus was UV-inactivated and applied to new WT or IFNAR null LET1 cells together with influenza virus. This conditioned media decreased the infectability of WT cells but not IFNAR null cells that cannot respond to type I IFNs (Fig. 8j,  k) . This suggests that epithelial cells are capable of producing quantities of type I IFNs that are sufficient for local restriction of influenza virus replication.
DISCUSSION
The LET1 immortalized mouse lung type I epithelial cell line described here has enabled us to characterize viral growth and host cell responses in cells that are a relevant replicative niche for influenza virus. We have characterized the viral mRNA and vRNA transcriptional kinetics and have shown that infected LET1 cells produce viral proteins and release infectious virions following infection with H1N1 and H3N2 human, swine and mouse-adapted viral strains. Influenza virus infection of LET1 cells upregulates the expression of many cytokines, antiviral genes and IFN-regulated genes, providing novel data on the response of lung type I epithelial cells and establishing a model for studying host response viral infection. LET1 cells produce a haemagglutinin (HA)-activating protease to allow a spreading influenza virus infection within these cultures, in contrast to many other cell models that require addition of exogenous trypsin. We detected expression of the Tmprss2 (transmembrane protease serine S1 member 2) trypsin-like serine protease in LET1 cells by qRT-PCR. mRNA levels of other proteases (Tmprss4 and Tmprss11d/HAT) shown previously to allow influenza virus spread, reviewed by Bertram et al. (2010a) , were below the level of detection (data not shown). Functional experiments will be required to determine whether Tmprss2 or another protease is necessary and sufficient for HA activation by LET1 cells (Böttcher et al., 2009 (Böttcher et al., , 2006 Böttcher-Friebertshäuser et al., 2010 , 2011 Bertram et al., 2010b ). An additional advantage of LET1 cells is their genetic manipulability by transfection or viral transduction to generate stable cell lines that permit gainof-function or loss-of-function studies of host genes.
Comparing LET1 cells generated from WT and IFNAR null mice has revealed an effective antiviral gene expression programme that is regulated by epithelial cell-derived type I IFN. Type I IFN has long been appreciated to induce an antiviral state in both infected and uninfected neighbouring cells (Isaacs & Lindenmann, 1987; Stetson & Medzhitov, 2006) . Virtually every nucleated cell can produce type I IFN when stimulated appropriately in vitro. However, type I IFN production in vivo depends on the virus tropism, the cell-specific expression of pattern recognition receptors and whether IFN production is positively regulated by IFN itself and therefore can occur within non-infected neighbouring cells (Barchet et al., 2002) . Alveolar macrophages and conventional dendritic cells (DCs) are early producers of type I IFN during viral lung infections, although production by non-haematopoietic cells was not examined (Kumagai et al., 2007) . Maximal type I IFN production by pDCs is most relevant once local mucosal defences have been breached and infection becomes systemic (Kumagai et al., 2007) and is IFNAR-independent (Barchet et al., 2002; Prakash et al., 2005) . (Prakash et al., 2005) . Low constitutive IRF7 levels in epithelial cells increases their dependence on IFNAR-dependent positive feedback to increase IRF7 abundance, promoting IFN-a secretion and maximal IFNdependent antiviral gene expression (Prakash et al., 2005) .
We observed a significant increase in viral RNA and protein in IFNAR null LET1 cells when compared with WT (m.o.i.55) and RNA isolated at baseline or after 24 h. Levels of viral M gene expression in the two cell types were equivalent. qRT-PCR was performed using primers specific for antiviral genes and shown relative to EF-1 expression (gene/EF-1¾1000). There were no significant differences between the gene expression in LET1 and primary cells (neither between uninfected cells nor between infected cells). **P,0.01, *P,0.05; ns, not significant; results are from two biological replicates. (Fig. 8f-j) . Type I IFN treatment induces the expression of hundreds of genes (Stark et al., 1998; van Boxel-Dezaire et al., 2006) belonging to five major classes/categories of antiviral mechanisms: (i) RNA modification, i.e. Oas2 and RNase L (Min & Krug, 2006; Silverman, 2007) ; and Adar (Ward et al., 2011) ; (ii) translation impairment, i.e. Pkr (Stojdl et al., 2000) ; (iii) protein tagging (Isg15, Lai et al., 2009) ; (iv) inhibition of nucleocapsid assembly (Mx; Arnheiter et al., 1990; Haller et al., 1979 Haller et al., , 2007 Staeheli et al., 1986) ; (iv) blockade of cytosolic entry (Ifitm3, Feeley et al., 2011); prevention of virus release (viperin/rsad2, Wang et al., 2007) and tetherin (Weidner et al., 2010; Yondola et al., 2011) . Low-level basal type I IFNs are also thought to play a homeostatic role by increasing the abundance of microbial detection and signalling components to potentiate a more rapid and robust response to subsequent activating signals (Levy et al., 2002) . We observed a significant decrease in basal expression of type I IFNregulated genes, suggesting that low levels of autocrine IFNs can regulate the basal antiviral activity of lung epithelial cells. In addition to the cell-intrinsic role of type I IFN in establishing a cell's antiviral capacity, the suppressive effect of media conditioned by infected LET1 cells (Fig.  8j, k In sum, we have characterized the host responses of type I lung epithelial cells to spreading influenza virus infection and demonstrated the capacity of epithelial cells to restrict viral replication independent of contributions from the haematopoietic compartment. We have observed that LET1 cells are permissive for replication of four RNA viruses: influenza virus, Sendai virus, VSV and EMCV. This novel and tractable type I lung epithelial cell model could be used to dissect viral growth and host responses to other lung pathogens such as respiratory syncytial virus. There is evidence that lung bacterial pathogens can interact with or directly infect lung epithelial cells, and LET1 cells could provide a model for studying host-pathogen interactions underlying clinically relevant diseases caused by Mycobacterium tuberculosis (Ehlers, 2009; Desvignes & Ernst, 2009 ), Staphylococcus aureus (Garzoni et al., 2007) , Streptococcus pneumoniae (Agarwal et al., 2010) , Klebsiella pheumoniae (Fumagalli et al., 1997; March et al., 2011) and Pseudomonas aeruginosa (Byfield et al., 2011; Hirakata et al., 2000 Hirakata et al., , 2002 . LET1 cells provide an in vitro model for detailed kinetic analysis and mechanistic studies of in vivo host or pathogen phenotypes within the epithelial compartment. (mTEC) generation was previously described (Dash et al., 2010) . To generate LET1 cells, lung cells were isolated from C57Bl/6 WT or IFNAR null mice using a modified dispase-agarose protocol (Herold et al., 2006) , cultured to yield lung epithelial type I cells (LET1) transdifferentiated from type II epithelial cells, then immortalized by transduction with MSCV-SV40 large T antigen and used after minimal passaging. Cell lines generated in two independent transductions gave the same viral replication and host gene expression phenotypes. FACS-sorted type I epithelial cells could not be immortalized. LET1 cells were cultured in DMEM containing 10 % heat-inactivated FBS, 2 mM L-glutamine and penicillin-streptomycin (complete DMEM), incubated at 37 uC, 5 % CO 2 , passaged using a brief trypsinization and subcultured 1 : 20 every 3 days. LET1 cells were seeded at 10 5 cells cm 22 on 0.4 mm polyester Transwell inserts coated with fibronectin and collagen and cultured in differentiation media [50 % DMEM, 50 % Ham-F12, Penicillin, Streptomycin, 2 % UltraSer G (BioSeptra), 10 ng ml 21 cholera toxin] for 5 days with media replacement every other day. Retinoic acid (10 27 M) was then added to the basolateral media and media was removed from the apical surface to allow cells to be grown at an air interface. Cells were cultured from 5 to 9 days with basolateral media replacement every other day, and cultures were infected once; basolateral media was restricted from flowing into the apical chamber. To measure cytokine secretion, media was added to the apical surface at the indicated time point and incubated at 37 uC for 30 min before collection. Apical and basolateral volumes were equivalent, and cytokine levels were calculated as pg ml Fig. 4 , viruses were inoculated in the allantoic cavity of 10 day embryonated chicken eggs. After 48 h of growth, eggs were chilled at 4 uC for 24 h and the allantoic fluid was harvested. Fluid was spun at 400 g for 5 min to remove particulates, aliquoted and stored at 280 uC. Sendai virus (Enders and Z strains; Zhan et al., 2007; Kato et al., 1996) was harvested from allantoic fluid. C57Bl/6 (Jackson) and IFNAR1 null mice (M. Gale and M. Kaja, University of Washington) (Müller et al., 1994) were housed in a specific pathogen-free barrier facility. All mice were cared for under specific pathogen-free conditions in an approved animal facility.
Ethics statement. All animal work was reviewed and approved by the appropriate institutional animal care and use committee following guidelines established by the Institute of Laboratory Animal Resources and approved by the Governing Board of the US National Research Council.
Flow cytometry. Lungs were perfused with PBS and digested using a dispase-agarose protocol (Herold et al., 2006; Marsh et al., 2009) . Red blood cells (RBCs) were removed using ACK lysis buffer and cells were separated using CD45 + microbeads and autoMACS separation or stained with cell lineage-specific antibodies and sorted (FACS Aria Molecular biology. RNA was isolated using Trizol. cDNA was synthesized from DNase-treated RNA using random primers, oligodT, or viral M gene-specific primers, and analysed by qRT-PCR using gene-specific primers and probes (ABI). Viral RNA was quantified by RT-PCR using primers specific for influenza virus M gene (Forward 59 CATGGAATGGCTAAAGACAAGACC, Reverse 59 CCATTAAGG-GCATTTTGGACA, Probe FAM-59 TTTGTGTTCACGCTCACCG-TGCCCATAMRA) and normalized to the level of mouse EF-1 or RNA obtained from equivalent volumes of supernatants (100 ml). LET1 cells were transduced with TRAF6 shRNA lentivirus (sc-36718V) or control scrambled shRNA lentivirus (sc-108080V, Santa Cruz Biotechnology) and stably selected using 2 mg ml 21 puromycin. Packaged retroviral MSCV-GFP, MSCV-miR-146a or lentiviral pLenti6 (±GFP) virus was transduced and selected using puromycin or 4 mg ml 21 blasticidin. Cells were transfected with pEF6-TRAF6 or empty vector using TransIT-LT1 lipid-based reagent and selected using 2 mg ml 21 puromycin.
Viral infection. Mice were infected with 10 5 p.f.u. PR8 for 24 h. Cells were plated at 0.5610 5 cells per well in a 24-well dish 18 h prior to infection in complete DMEM. Cells were rinsed once with PBS to remove protease inhibitors present in FBS and infected at an m.o.i. of 5 unless otherwise indicated for 1 h in OptiMEM in the absence of exogenous trypsin. The inoculum was removed by washing twice with PBS after 1 h, and cells were cultured in OptiMEM for 18-24 h. RNA was collected at 1 h using Trizol to quantify the initial level of viral infection; RNA, protein and cell supernatants were collected at the indicated time points over 24 h. To permit comparison between experiments, viral RNA levels at 24 h were normalized to initial viral RNA levels at 1 h, where indicated. Influenza virus TCID 50 assays were performed by plating serial dilutions of 24 h cell supernatants on MDCK cells and scoring viable wells after 3-5 days following staining by crystal violet. Cells were infected with EMCV (m.o.i.50.01) and VSV (m.o.i.50.01) in complete DMEM for 1 h; cells were then washed, and incubated for 24 h. EMCV and VSV plaque assays were performed using Vero cells and a methyl cellulose overlay. For Sendai virus infections, LET1 or LLC-MK2 cells were plated at 3610 4 cells per well in 96-well plates. LET1 cells were grown in DMEM/10 % glutamine/2 mM FCS, additional L-glutamine and 50 mg ml 21 gentamicin. LLC-MK2 cells were grown in MEM/0.23 % sodium bicarbonate/5 % FCS/5 mM glutamine, and 50 mg ml 21 gentamicin. Cells were cultured overnight at 37 uC/5 % CO 2 . Cells were washed three times with Dulbecco's PBS (DPBS) and virus added at an m.o.i. of 5 in DMEM with glutamine/0 % FCS and incubated at 37 uC for 1 h. Virus was removed and cells washed five times with DPBS. 200 ml per well DMEM with glutamine/0.1 % BSA/50 mg ml 21 gentamicin (±5 mg ml 21 acetylated trypsin) were added and plates incubated at 37 uC/5 % CO 2 . Supernatants containing released virus were collected from triplicate wells at the indicated time points and stored at 280 uC. To quantify titres of released virus, MK2 cells were plated in 96-well plates for next-day confluency. Serial dilutions of supernatants were made to 10 8 in DMEM with glutamine/0.1 % BSA/ 5 mg ml 21 acetylated trypsin/2 mM additional L-glutamine. Virus was placed on MK2 cells (100 ml per well) for 1 h, after which 100 ml additional media were added. Plates were incubated at 37 uC for 3 days. HA assays were performed with chicken RBCs and TCID 50 were calculated. Statistical analysis. P values were determined using an unpaired two-tailed Student's t-test assuming equal variances of all experimental datasets.
described in (f) and stained for viral NP protein after 6 h or 24 h; the percentage of infected cells (means±SEM) are shown for n53. (j) Supernatant was generated from LET1 cells infected for 24 h (m.o.i.55) or mock-infected cells. Supernatants were UV treated, which rendered them non-infectious, as shown by no staining for viral NP protein following incubation of new LET1 cells with UV-treated supernatants for 24 h and flow cytometry. These two supernatants were transferred to WT or IFNAR null cells together with influenza virus (PR8, m.o.i.55) for 18 h. Cells were stained for viral NP protein and representative flow cytometry plots are shown. Data are from three independent experiments performed in triplicate. (k) The fractional decrease in infectivity following incubation with LET1-conditioned media as measured by flow cytometry (mean±SEM for three independent experiments performed in triplicate).
